Luke M. Beshar, EVP & CFO at NPS PHARMACEUTICALS INC (NPSP), sold 45,150 shares at $14.18 ($640K) on 2013-05-09, disclosed to the SEC on 2013-05-13.
Scheduled sale ($640k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TARA | BUY | 2022-03-14 | $45K | — | Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |